HK Stock MarketDetailed Quotes

09906 HONLIV HEALTH

Watchlist

2.520
0.0000.00%

Market Closed Apr 26 16:08 CST

1.51BMarket Cap36.00P/E (TTM)

HONLIV HEALTH Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

(Q9)Sep 30, 2019

(Q6)Jun 30, 2019

Cash flow from operating activities

Earning before tax

----

24.69%63.02M

----

63.82%50.54M

----

-54.95%30.85M

----

-30.46%68.48M

-21.27%61.92M

----

Profit adjustment

Interest expense - adjustment

----

--19.29M

----

Impairment and provisions:

--0

7,447.06%6.42M

--0

-98.16%85K

--0

18,340.00%4.61M

--0

25.00%25K

--0

-Impairment of property, plant and equipment (reversal)

----

--4.45M

----

-Impairment of trade receivables (reversal)

----

2,209.41%1.96M

----

-98.16%85K

----

18,340.00%4.61M

----

25.00%25K

----

Revaluation surplus:

--0

Asset sale loss (gain):

--0

-68.33%19K

--0

2,900.00%60K

--0

-94.29%2K

--0

108.18%35K

-27.27%8K

--0

-Loss (gain) on sale of property, machinery and equipment

----

-68.33%19K

----

2,900.00%60K

----

-94.29%2K

----

108.18%35K

-27.27%8K

----

Depreciation and amortization:

--0

62.25%54.69M

--0

18.25%33.71M

--0

16.47%28.51M

--0

1.61%24.47M

0.61%18.17M

--0

-Depreciation

----

62.31%54.23M

----

18.09%33.41M

----

16.26%28.29M

----

1.52%24.34M

0.31%18.06M

----

-Amortization of intangible assets

----

73.75%523K

----

42.65%301K

----

54.01%211K

----

20.18%137K

114.58%103K

----

-Other depreciation and amortization

----

-1,000.00%-66K

----

---6K

----

Financial expense

----

-33.24%8.71M

----

--13.04M

----

112.51%28M

120.73%22.24M

----

Exchange Loss (gain)

----

-441.22%-10.17M

----

-74.82%2.98M

----

--11.83M

----

Operating profit before the change of operating capital

--0

22.18%122.68M

--0

5.60%100.41M

--0

-21.43%95.09M

--0

-10.58%121.02M

-4.18%102.33M

--0

Change of operating capital

Inventory (increase) decrease

----

63.25%-2.36M

----

-366.03%-6.43M

----

146.91%2.42M

----

6.00%-5.15M

346.41%4.09M

----

Accounts receivable (increase)decrease

----

-72.48%-14.07M

----

40.58%-8.16M

----

-148.51%-13.73M

----

196.68%28.31M

211.17%20.75M

----

Accounts payable increase (decrease)

----

112.84%26.76M

----

225.23%12.57M

----

-140.88%-10.04M

----

-51.04%24.56M

-133.79%-20.18M

----

Cash from business operations

2.99%52.99M

27.96%133.01M

31.05%51.45M

25.91%103.95M

18.72%39.26M

-53.42%82.56M

-66.67%33.07M

29.40%177.23M

18.71%127.76M

--99.24M

Other taxs

35.29%-7.07M

-16.27%-14.54M

-63.47%-10.92M

-57.36%-12.5M

-324.40%-6.68M

91.29%-7.95M

---1.57M

---91.19M

---90.17M

----

Interest received - operating

83.97%482K

----

--262K

----

Special items of business

----

-37.12%5.55M

----

3.85%8.83M

----

161.77%8.5M

153.87%20.78M

----

Net cash from operations

13.76%46.41M

29.56%118.47M

25.21%40.8M

22.56%91.44M

3.44%32.58M

-13.28%74.61M

-68.26%31.5M

-37.18%86.05M

-65.07%37.59M

--99.24M

Cash flow from investment activities

Interest received - investment

----

-28.35%647K

----

14.16%903K

----

12.04%791K

82.95%236K

1,757.89%706K

2,180.00%684K

--129K

Loan receivable (increase) decrease

----

--0

-651.82%-45.98M

---49.44M

Purchase of fixed assets

-764.56%-37.5M

62.93%-18.91M

75.07%-4.34M

36.57%-51.02M

-47.24%-17.4M

-22.99%-80.43M

76.62%-11.82M

-843.94%-65.4M

-1,030.21%-59.9M

---50.53M

Purchase of intangible assets

2.30%-298K

-161.99%-896K

-66.67%-305K

18.76%-342K

-17.31%-183K

-29.54%-421K

25.71%-156K

---325K

---210K

Net cash from investment operations

-714.17%-37.79M

62.03%-19.16M

73.60%-4.64M

36.97%-50.46M

-49.80%-17.58M

-23.14%-80.06M

88.27%-11.74M

-3,552.73%-65.02M

-3,542.36%-105.41M

---100.06M

Net cash before financing

-76.17%8.62M

142.32%99.31M

141.03%36.15M

852.26%40.98M

-24.09%15M

-125.91%-5.45M

2,518.73%19.76M

-84.85%21.03M

-161.27%-67.82M

---817K

Cash flow from financing activities

New borrowing

3.92%143.41M

-12.30%164M

-16.36%138M

-12.21%187M

-18.72%165M

-44.31%213M

-44.31%203M

-18.01%382.5M

-15.35%382.5M

--364.5M

Refund

30.10%-115.33M

14.90%-210M

9.25%-165M

-3.72%-246.77M

18.24%-181.81M

32.68%-237.93M

30.32%-222.38M

23.12%-353.41M

11.30%-346.61M

---319.16M

Issuing shares

----

--283.89M

----

Interest paid - financing

34.38%-3.24M

37.47%-9.35M

39.52%-4.93M

28.67%-14.96M

27.65%-8.16M

21.76%-20.97M

-24.59%-11.28M

-97.53%-26.8M

-105.88%-20.81M

---9.05M

Dividends paid - financing

----

24.52%-7.23M

---7.23M

79.27%-9.58M

----

Absorb investment income

----

6.22%84.97M

----

Issuance expenses and redemption of securities expenses

----

-196.82%-3.26M

-446.12%-14.09M

0.45%-1.1M

---2.58M

----

---1.1M

Other items of the financing business

-2,771.59%-15.36M

-2,812.21%-62.5M

30.07%-535K

-41.37%-2.15M

0.00%-765K

-3.69%-1.52M

9.47%-765K

99.12%-1.46M

98.66%-2.22M

---845K

Net cash from financing operations

129.19%9.48M

-53.30%-117.85M

-11.98%-32.47M

-135.73%-76.87M

27.04%-29M

192.16%215.16M

-215.71%-39.74M

152.98%73.64M

226.40%97.84M

--34.35M

Effect of rate

-78.13%1.02M

441.22%10.17M

494.74%4.65M

74.82%-2.98M

---1.18M

---11.83M

----

Net Cash

390.88%18.09M

48.35%-18.54M

126.34%3.69M

-117.11%-35.89M

29.95%-14M

121.51%209.71M

-159.59%-19.98M

56,452.38%94.67M

-9.76%30.03M

--33.53M

Begining period cash

-3.18%255.24M

-12.85%263.61M

189.17%302.48M

953.39%104.6M

-1.66%9.93M

--9.93M

Cash at the end

0.88%274.35M

-3.18%255.24M

-5.34%271.95M

-12.85%263.61M

239.51%287.3M

189.17%302.48M

94.72%84.62M

953.39%104.6M

-7.88%39.96M

--43.46M

Cash balance analysis

Cash and cash equivalent balance

--0

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

PricewaterhouseCoopers

	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019	(Q9)Sep 30, 2019	(Q6)Jun 30, 2019
Cash flow from operating activities
Earning before tax	----	24.69%63.02M	----	63.82%50.54M	----	-54.95%30.85M	----	-30.46%68.48M	-21.27%61.92M	----
Profit adjustment
Interest expense - adjustment	----	----	----	----	----	--19.29M	----	----	----	----
Impairment and provisions:	--0	7,447.06%6.42M	--0	-98.16%85K	--0	18,340.00%4.61M	--0	25.00%25K	--0	--0
-Impairment of property, plant and equipment (reversal)	----	--4.45M	----	----	----	----	----	----	----	----
-Impairment of trade receivables (reversal)	----	2,209.41%1.96M	----	-98.16%85K	----	18,340.00%4.61M	----	25.00%25K	----	----
Revaluation surplus:	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Asset sale loss (gain):	--0	-68.33%19K	--0	2,900.00%60K	--0	-94.29%2K	--0	108.18%35K	-27.27%8K	--0
-Loss (gain) on sale of property, machinery and equipment	----	-68.33%19K	----	2,900.00%60K	----	-94.29%2K	----	108.18%35K	-27.27%8K	----
Depreciation and amortization:	--0	62.25%54.69M	--0	18.25%33.71M	--0	16.47%28.51M	--0	1.61%24.47M	0.61%18.17M	--0
-Depreciation	----	62.31%54.23M	----	18.09%33.41M	----	16.26%28.29M	----	1.52%24.34M	0.31%18.06M	----
-Amortization of intangible assets	----	73.75%523K	----	42.65%301K	----	54.01%211K	----	20.18%137K	114.58%103K	----
-Other depreciation and amortization	----	-1,000.00%-66K	----	---6K	----	----	----	----	----	----
Financial expense	----	-33.24%8.71M	----	--13.04M	----	----	----	112.51%28M	120.73%22.24M	----
Exchange Loss (gain)	----	-441.22%-10.17M	----	-74.82%2.98M	----	--11.83M	----	----	----	----
Operating profit before the change of operating capital	--0	22.18%122.68M	--0	5.60%100.41M	--0	-21.43%95.09M	--0	-10.58%121.02M	-4.18%102.33M	--0
Change of operating capital
Inventory (increase) decrease	----	63.25%-2.36M	----	-366.03%-6.43M	----	146.91%2.42M	----	6.00%-5.15M	346.41%4.09M	----
Accounts receivable (increase)decrease	----	-72.48%-14.07M	----	40.58%-8.16M	----	-148.51%-13.73M	----	196.68%28.31M	211.17%20.75M	----
Accounts payable increase (decrease)	----	112.84%26.76M	----	225.23%12.57M	----	-140.88%-10.04M	----	-51.04%24.56M	-133.79%-20.18M	----
Cash from business operations	2.99%52.99M	27.96%133.01M	31.05%51.45M	25.91%103.95M	18.72%39.26M	-53.42%82.56M	-66.67%33.07M	29.40%177.23M	18.71%127.76M	--99.24M
Other taxs	35.29%-7.07M	-16.27%-14.54M	-63.47%-10.92M	-57.36%-12.5M	-324.40%-6.68M	91.29%-7.95M	---1.57M	---91.19M	---90.17M	----
Interest received - operating	83.97%482K	----	--262K	----	----	----	----	----	----	----
Special items of business	----	----	----	-37.12%5.55M	----	3.85%8.83M	----	161.77%8.5M	153.87%20.78M	----
Net cash from operations	13.76%46.41M	29.56%118.47M	25.21%40.8M	22.56%91.44M	3.44%32.58M	-13.28%74.61M	-68.26%31.5M	-37.18%86.05M	-65.07%37.59M	--99.24M
Cash flow from investment activities
Interest received - investment	----	-28.35%647K	----	14.16%903K	----	12.04%791K	82.95%236K	1,757.89%706K	2,180.00%684K	--129K
Loan receivable (increase) decrease	----	----	----	----	----	----	----	--0	-651.82%-45.98M	---49.44M
Purchase of fixed assets	-764.56%-37.5M	62.93%-18.91M	75.07%-4.34M	36.57%-51.02M	-47.24%-17.4M	-22.99%-80.43M	76.62%-11.82M	-843.94%-65.4M	-1,030.21%-59.9M	---50.53M
Purchase of intangible assets	2.30%-298K	-161.99%-896K	-66.67%-305K	18.76%-342K	-17.31%-183K	-29.54%-421K	25.71%-156K	---325K	---210K	---210K
Net cash from investment operations	-714.17%-37.79M	62.03%-19.16M	73.60%-4.64M	36.97%-50.46M	-49.80%-17.58M	-23.14%-80.06M	88.27%-11.74M	-3,552.73%-65.02M	-3,542.36%-105.41M	---100.06M
Net cash before financing	-76.17%8.62M	142.32%99.31M	141.03%36.15M	852.26%40.98M	-24.09%15M	-125.91%-5.45M	2,518.73%19.76M	-84.85%21.03M	-161.27%-67.82M	---817K
Cash flow from financing activities
New borrowing	3.92%143.41M	-12.30%164M	-16.36%138M	-12.21%187M	-18.72%165M	-44.31%213M	-44.31%203M	-18.01%382.5M	-15.35%382.5M	--364.5M
Refund	30.10%-115.33M	14.90%-210M	9.25%-165M	-3.72%-246.77M	18.24%-181.81M	32.68%-237.93M	30.32%-222.38M	23.12%-353.41M	11.30%-346.61M	---319.16M
Issuing shares	----	----	----	----	----	--283.89M	----	----	----	----
Interest paid - financing	34.38%-3.24M	37.47%-9.35M	39.52%-4.93M	28.67%-14.96M	27.65%-8.16M	21.76%-20.97M	-24.59%-11.28M	-97.53%-26.8M	-105.88%-20.81M	---9.05M
Dividends paid - financing	----	----	----	----	----	24.52%-7.23M	---7.23M	79.27%-9.58M	----	----
Absorb investment income	----	----	----	----	----	----	----	6.22%84.97M	6.22%84.97M	----
Issuance expenses and redemption of securities expenses	----	----	----	----	-196.82%-3.26M	-446.12%-14.09M	0.45%-1.1M	---2.58M	----	---1.1M
Other items of the financing business	-2,771.59%-15.36M	-2,812.21%-62.5M	30.07%-535K	-41.37%-2.15M	0.00%-765K	-3.69%-1.52M	9.47%-765K	99.12%-1.46M	98.66%-2.22M	---845K
Net cash from financing operations	129.19%9.48M	-53.30%-117.85M	-11.98%-32.47M	-135.73%-76.87M	27.04%-29M	192.16%215.16M	-215.71%-39.74M	152.98%73.64M	226.40%97.84M	--34.35M
Effect of rate	-78.13%1.02M	441.22%10.17M	494.74%4.65M	74.82%-2.98M	---1.18M	---11.83M	----	----	----	----
Net Cash	390.88%18.09M	48.35%-18.54M	126.34%3.69M	-117.11%-35.89M	29.95%-14M	121.51%209.71M	-159.59%-19.98M	56,452.38%94.67M	-9.76%30.03M	--33.53M
Begining period cash	-3.18%255.24M	-12.85%263.61M	-12.85%263.61M	189.17%302.48M	189.17%302.48M	953.39%104.6M	953.39%104.6M	-1.66%9.93M	-1.66%9.93M	--9.93M
Cash at the end	0.88%274.35M	-3.18%255.24M	-5.34%271.95M	-12.85%263.61M	239.51%287.3M	189.17%302.48M	94.72%84.62M	953.39%104.6M	-7.88%39.96M	--43.46M
Cash balance analysis
Cash and cash equivalent balance	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--
Auditor	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

09906 HONLIV HEALTH

HONLIV HEALTH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target